SCHEMBL20928367

SCHEMBL20928367

Nc1ccnc2[nH]c(-c3ccccc3)cc12

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.56
ADORA1 P30542 2/20 0.56
CCNB2 O95067 1/20 0.56
CDK1 P06493 1/20 0.56
CCNB1 P14635 1/20 0.56
GSK3A P49840 1/20 0.56
GSK3B P49841 1/20 0.56
CDK5 Q00535 1/20 0.56
CDK5R1 Q15078 1/20 0.56
CCNB3 Q8WWL7 1/20 0.56
EGFR P00533 9/20 0.50
MAPK14 Q16539 4/20 0.50
PARP1 P09874 1/20 0.50
CSF1R P07333 3/20 0.48
RIPK1 Q13546 1/20 0.46
PRMT5 O14744 1/20 0.46
KIT P10721 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20927913 0.86 PIK3C3 (0.51) ADORA2AADORA1EGFRCSF1RKIT
SCHEMBL20927912 0.81 CDK5 (0.58) ADORA2AADORA1CCNB2CDK1CCNB1
SCHEMBL12330482 0.80 CCNB2 (0.61) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL20928261 0.80 EGFR (0.50) EGFRRIPK1KIT
SCHEMBL20928159 0.80 MITF (0.47) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL1778024 0.80 ADORA2A (0.56) ADORA2AADORA1CCNB2CDK1CCNB1
SCHEMBL31240593 0.80 CDC7 (0.59) ADORA2AADORA1CCNB2CDK1CCNB1
SCHEMBL16041244 0.80 CDC7 (0.59) ADORA2AADORA1CCNB2CDK1CCNB1
SCHEMBL3604759 0.80 ADORA2A (0.56) ADORA2AADORA1CCNB2CDK1CCNB1
SCHEMBL20927949 0.80 TBK1 (0.53) CCNB2CDK1CCNB1GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115605460-A Synthesis of heterocyclic compounds 普莱希科公司(US) 2023-01-13 CN disclosed
WO-2019079649-A1 SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE BLUEPRINT MEDICINES CORPORATION (US) 2019-04-25 WO disclosed